Published in TB and Outbreaks Week, January 22nd, 2008
"The goal was to determine whether dexamethasone reduced the risk of death at 1 month and the risk of death or disability at 6 months. A total of 217 patients were assigned to the dexamethasone group, and 218 to the placebo group. Bacterial meningitis was confirmed in 300 patients (69.0%), probable meningitis was diagnosed in 123 patients (28.3%), and an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week